market access insights

PMA Insights: Week 29


The latest news and insights from the Pricing, Market Access and Pharmaceutical space:

  • NICE joins international consortium aimed at improving clinical decision making for lung cancer patients
  • EMA phases out extraordinary COVID-19 regulatory flexibilities
  • Endometrial cancer patients gain early access to GSK’s Jemperli
  • The wait times for new medications in France are on the rise

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.